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The acquisition and assimilation strategies followed by members of the infant gut
microbiota to retrieve nitrogen from the gut lumen are still largely unknown. In particular,
no information on these metabolic processes is available regarding bifidobacteria, which
are among the first microbial colonizers of the human intestine. Here, evaluation of amino
acid auxotrophy and prototrophy of Bifidobacterium bifidum, with particular emphasis on
B. bifidum strain PRL2010 (LMG S-28692), revealed a putative auxotrophy for cysteine.
In addition, we hypothesized that cysteine plays a role in the oxidative stress response
in B. bifidum. The use of glutathione as an alternative reduced sulfur compound did not
alleviate cysteine auxotrophy of this strain, though it was shown to stimulate expression
of the genes involved in cysteine biosynthesis, reminiscent of oxidative stress response.
When PRL2010 was grown on a medium containing complex substrates, such as whey
proteins or casein hydrolysate, we noticed a distinct growth-promoting effect of these
compounds. Transcriptional analysis involving B. bifidum PRL2010 cultivated on whey
proteins or casein hydrolysate revealed that the biosynthetic pathways for cysteine
and methionine are modulated by the presence of casein hydrolysate. Such findings
support the notion that certain complex substrates may act as potential prebiotics for
bifidobacteria in their ecological niche.
Keywords: bifidobacteria, chemically defined medium, genomics, microbiota
INTRODUCTION
The gut lumen contains a very complex mixture of compounds from alimentary and endogenous
origins together with living microorganisms. The intestinal microbiota is metabolically active
and plays a signiﬁcant role in host physiology and metabolism (Hamer et al., 2012). The ability
to metabolize peptides and amino acids is shared by a large number of bacteria ranging from
saccharolytic bacteria to obligate amino acid fermenters present in gut microbiota (Davila et al.,
2013). Peptides are the preferred substrates over free amino acids for many colonic bacteria,
probably due to kinetic advantages of peptide uptake systems. Moreover, nitrogen source, such
as amino acids, are fermented to short-chain fatty acids and organic acids, representing energy fuel
for the colonic mucosa (Davila et al., 2013).
Milk proteins and peptides such as lactoferrin, lactoperoxidase, and lysozyme are reported to
provide a non-immune defense against microbial infections (Schanbacher et al., 1997). In addition,
they are known to stimulate growth of several members of the human infant microbiota such
Frontiers in Microbiology | www.frontiersin.org 1 November 2015 | Volume 6 | Article 1331
Ferrario et al. Sulfur Amino Acid Metabolism of PRL2010
Lactobacillus and Bifidobacterium (Liepke et al., 2002; McCann
et al., 2006). In this latter ecological context, the bacterial
population is dominated by biﬁdobacteria, which remain a
prominent component of the gut microbiota until weaning
(Turroni et al., 2012a; Duranti et al., 2015; Underwood et al.,
2015). Member of the genus Bifidobacterium are anaerobic
microorganisms, typically resident in the gastro intestinal tract
of mammals and insects (Lugli et al., 2014), where they are
known to interact with their hosts using various genetic strategies
(O’Connell Motherway et al., 2011; Fanning et al., 2012; Ventura
et al., 2012; Turroni et al., 2014).
Among host-derived nutrients, milk proteins signiﬁcantly
inﬂuence the composition of the gut microbiota, supplying these
microorganisms with nitrogen and amino acids (Liepke et al.,
2002). Enhancement of (biﬁdo)bacterial growth is frequently
associated with milk proteins and the peptides that arise from
the hydrolysis of these proteins (Nagpal et al., 2011; Lonnerdal,
2013).
Compared to carbon metabolism, for which a large body of
scientiﬁc data is available (Pokusaeva et al., 2011; Marcobal et al.,
2013), only very limited knowledge is available on the acquisition
and assimilation processes that are used by members of the infant
gut microbiota to retrieve nitrogen from the gut lumen (Liepke
et al., 2002). For Gram positive bacteria, nitrogen metabolism has
been investigated in Lactobacillus delbrueckii subsp. bulgaricus
(Liu et al., 2012), Lactobacillus rhamnosus (Lebeer et al., 2007)
and Bacillus sp. (Fisher, 1999; Even et al., 2006).
Recently, speciﬁc interest has been directed toward sulfur-
containing amino acids and global control of cysteine and
methionine metabolism in both Gram positive and negative
bacteria, such as Lactococcus lactis, Salmonella sp., Vibrio fischeri
and Clostridium perfringens (Fernandez et al., 2002; Andre
et al., 2010; Alvarez et al., 2015; Singh et al., 2015). Cysteine
biosynthesis is the key mechanism by which inorganic sulfur
is reduced and incorporated into organic compounds (Kredich,
1992), where it plays an essential role in the formation of
the catalytic sites of several enzymes, or protein folding and
assembly via the formation of disulﬁde bonds (Mihara and
Esaki, 2002). Sulfur-containing compounds that are used for the
synthesis of cysteine and methionine are transported into the
bacterial cell through diﬀerent mechanisms: the ﬁrst involves
sulfate permease related to inorganic phosphate transporters
(CysC) and then the reduction of sulfate to sulﬁde (Mansilla and
de Mendoza, 2000) (Figure 1). The second involves aliphatic
sulfonate ATP-binding cassette (ABC) transporters (SsuBD)
(van der Ploeg et al., 1998) and the subsequent conversion
into sulﬁde by an FMNH monooxygenase (Figure 1). The
following reaction of sulﬁde with O-acetyl-L-serine (OAS)
results in cysteine synthesis by the action of an O-acetylserine
thiol-lyase (Bogicevic et al., 2012). Alternatively, cysteine can
be directly transported inside the cell by symporter proteins
(TcyBCP) (Burguiere et al., 2004). Methionine biosynthesis is
closely linked to cysteine production by the action of serine
acetyltransferase, which uses cysteine and anO-acetylhomoserine
to generate cystathionine, where the latter compound is then
converted to homocysteine and methionine (Fernandez et al.,
2002) (Figure 1).
In this study, in order to understand the role of the
biﬁdobacterial population in the utilization of nitrogen available
in the human gut, we evaluated the amino acid metabolism
of the infant stool isolate B. bifidum PRL2010 (LMG S-28692),
a biﬁdobacterial prototype for analysis of interactions between
microbes and the intestinal mucosa (Turroni et al., 2013), by
coupling physiological data on a chemically deﬁned medium
(CDM) with transcriptional analysis. Speciﬁc emphasis was
placed on sulfur amino acids/metabolism of PRL2010 since these
amino acids are particularly important for the bacterial cells
of gut commensals in coping against gut related stresses (e.g.,
oxidative stress) (Even et al., 2006).
Furthermore, PRL2010 metabolism of complex substrates
from milk such as casein hydrolysate and whey proteins was
investigated.
MATERIALS AND METHODS
Bacterial Strains and DNA Extraction
Biﬁdobacterial strains used in this study are reported in Table 1.
Strains were grown anaerobically in de Man, Rogosa, Sharpe
(MRS) medium (Scharlau, Spain), which was supplemented with
0.05% L-cysteine-HCl and incubated at 37◦C for 16 h. Anaerobic
conditions were achieved by the use of an anaerobic cabinet
(Ruskin), in which the atmosphere consisted of 10% CO2, 80%
N2, and 10% H2.
Bifidobacterium CDM Development
For amino acid auxotrophy and prototrophy tests, a CDM
was employed based on a previously described formulation
(Petry et al., 2000; Cronin et al., 2012) for Lactobacillus and
Bifidobacterium, with some modiﬁcations. Brieﬂy, to the already
reported CDM, 50 mg/l of guanine and 4.0 mg/l of thiamine was
added. Several simple sugars were screened including glucose,
fructose, galactose, lactose, ribose, xylose, fucose, mannose, and
rhamnose. All carbohydrates were added at 2% (w/w). The
medium was sterilized by ﬁltration (0.22 μm). When the CDM
was prepared without amino acids it is termed basal CDM
(bCDM). All components of CDM were purchased from Sigma
(USA).
Amino Acid and Nitrogen Growth Assay
Cell growth on CDM was monitored by measuring the optical
density of cultures at 600 nm (OD 600) using a plate reader
(Biotek, Winooski, VT, USA). The plate reader was run in
discontinuous mode, with absorbance readings performed after
24 h of incubation and preceded by 30 s of shaking at medium
speed. Bacteria were cultivated in the wells of a 96-well microtiter
plate, with each well containing a diﬀerent amino acid, and
incubated in an anaerobic cabinet.
For all growth tests, cells were recovered from an overnight
MRS broth culture, centrifuged at 3000 rpm for 5 min in
anaerobiosis, and washed with bCDM to remove protein and
sugar residues. In each of the 96-wells of the microplate,
135 μl of medium was inoculated with 15 μl of washed
cells diluted to OD 1.0 with bCDM, obtaining a ﬁnal
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FIGURE 1 | Schematic representation of the metabolic pathways for sulfur amino acid in Gram positive bacteria. The different ORFs of Bifidobacterium
bifidum PRL2010 encoding the predicted enzymes are indicated. The metabolic steps present in Gram positive bacteria but absent in PRL2010 (sulfate assimilation
and glutathione synthesis) are indicated by gray arrows. Molecule involved are reported as follow: serine Ser, O-acetyl-L-serine OAS, cysteine Cys, homoserine hSer,
O-succinylhomoserine O-ShSer, cystathionine Cyst, homocysteine hCys and methionine Met.
inoculum OD of 0.1. Wells were covered with 30 μl of sterile
mineral oil in order to maintain anaerobic conditions. Cultures
were grown in biologically independent triplicates and the
resulting growth data were expressed as the means from these
replicates.
Once it had been established that CDM supports
biﬁdobacterial growth, amino acid assays were performed
using CDM in which individual amino acids were omitted
or with bCDM supplemented with 0.2 g/l of a particular
amino acid. To understand amino acid metabolism and in
particular the metabolism of sulfur-containing amino acids
derived from complex substrates, bCDM was supplemented
with 2–0.5% (w/w) of whey protein or casein hydrolysate
(Sigma). To test the inﬂuence of reduced sulfur substrate
instead cysteine to PRL2010 growth, 5 mM of reduced
glutathione (Sigma) was added to bCDM formulation
without any other amino acid (bCDM + Glut). To evaluate
the utilization of source of sulfur and nitrogen available
in the gut environment, 0.5 g/l of taurine was added to
bCDM.
Identification of Genes Involved in
Sulfur-containing Amino Acid
Metabolism
The identiﬁcation of genes involved in cysteine and methionine
metabolism in PRL2010 and other B. bifidum strains was
performed by using the BLASTP program (Gish and States,
1993). For the BLAST search, previously identiﬁed genes involved
in sulfur metabolism of lactic acid bacteria were used (Liu et al.,
2012). Twenty bp oligonucleotides for RT-qPCR experiments
were manually designed on identiﬁed putative genes to obtain
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TABLE 1 | Bifidobacterial strains used in this study.
Bacteria Strainsa Genome accession
numbers
B. actinocoloniiforme DSM 22766 JGYK00000000
B. adolescentis ATCC 15703 AP009256.1
B. angulatum LMG 11039 JGYL00000000
B. animalis subsp. animalis LMG 10508 JGYM00000000
B. animalis subsp. lactis DSM 10140 CP001606.1
B. asteroides LMG 10735
(PRL2011)
CP003325.1
B. biavatii DSM 23969 JGYN00000000
B. bifidum LMG 11041 JGYO00000000
B. bifidum PRL2010 CP001840
B. bifidum 85B JSDU00000000
B. bifidum 324B JSDT00000000
B. bifidum 156B JSDS00000000
B. bifidum LMG 11583 JSDZ00000000
B. bifidum LMG 11582 JSDY00000000
B. bifidum LMG 13200 JSEB00000000
B. bifidum LMG 13195 JSEA00000000
B. bohemicum DSM 22767 JGYP00000000
B. bombi DSM 19703 ATLK00000000
B. boum LMG 10736 JGYQ00000000
B. breve LMG 13208 JGYR00000000
B. callitrichos DSM 23973 JGYS00000000
B. catenulatum LMG 11043 JGYT00000000
B. choerinum LMG 10510 JGYU00000000
B. coryneforme LMG 18911 CP007287
B. crudilactis LMG 23609 JHAL00000000
B. cuniculi LMG 10738 JGYV00000000
B. dentium LMG 11405
(Bd1)
CP001750.1
B. gallicum LMG 11596 JGYW00000000
B. gallinarum LMG 11586 JGYX00000000
B. indicum LMG 11587 CP006018
B. kashiwanohense DSM 21854 JGYY00000000
B. longum subsp. infantis ATCC 15697 AP010889.1
B. longum subsp. longum LMG 13197 JGYZ00000000
B. longum subsp. suis LMG 21814 JGZA00000000
B. magnum LMG 11591 JGZB00000000
B. merycicum LMG 11341 JGZC00000000
B. minimum LMG 11592 JGZD00000000
B. mongoliense DSM 21395 JGZE00000000
B. moukalabense DSM 27321 AZMV00000000.1
B. pseudocatenulatum LMG 10505 JGZF00000000
B. pseudolongum subsp.
globosum
LMG 11596 JGZG00000000
B. pseudolongum subsp.
pseudolongum
LMG 11571 JGZH00000000
B. psychraerophilum LMG 21775 JGZI00000000
B. pullorum LMG 21816 JGZJ00000000
B. reuteri DSM 23975 JGZK00000000
B. ruminantium LMG 21811 JGZL00000000
B. saeculare LMG 14934 JGZM00000000
B. saguini DSM 23967 JGZN00000000
B. scardovii LMG 21589 JGZO00000000
(Continued)
TABLE 1 | Continued
Bacteria Strainsa Genome accession
numbers
B. stellenboschense DSM 23968 JGZP00000000
B. stercoris DSM 24849 JGZQ00000000
B. subtile LMG 11597 JGZR00000000
B. thermacidophilum
subsp. porcinum
LMG 21689 JGZS00000000
B. thermacidophilum
subsp. thermacidophilum
LMG 21395 JGZT00000000
B. thermophilum JCM 1207 JGZV00000000
B. tsurumiense JCM 13495 JGZU00000000
aATCC, American Type Culture Collection, USA. LMG, Belgian Co-ordinated
Collection of Microorganisms-Bacterial Collection, Belgium. DSM, German
Collection of Microorganism and Cell Cultures, Germany. JCM, Japan Collection
of Microorganisms, Japan.
amplicons with a size ranging from 150 to 200 bp. Primers were
checked with Primer Blast (Ye et al., 2012) and listed in Table 2.
RNA Isolation, Reverse Transcription and
RT-qPCR
Total RNA was isolated from PRL2010 cultures grown in CDM,
bCDM supplemented with cysteine, or bCDM supplemented
with cysteine and whey protein or casein hydrolysate (2% w/w).
PRL2010 cells grown in MRS was used as a control condition.
Cultures were grown in biologically independent triplicates. Cells
were harvested by centrifugation step at 4000 × g for 5′ at 4◦C
when cells had reached late exponential phase (OD values of 0.8–
1.0, except for bCDM supplemented with glutathione where cells
were harvested at OD 0.35). Cell pellets were resuspended in
500 μl of RNAprotect reagent (Qiagen, UK) and mechanically
lysed by inclusion of 0.1 mm zirconium–silica beads (Biospec
Products, Bartlesville, OK, USA) and by subjecting the sample
to three 2 min pulses at maximum speed in a bead beater
(Biospec Products, Bartlesville, OK, USA) with intervals of 3 min
on ice. RNA was extracted with the RNeasy mini kit (Qiagen)
as reported in the manufacturer’s instructions. Quality and
integrity of the RNA was checked by Tape station 2200 (Agilent
Technologies, USA) analysis and only samples displaying a RIN
value above seven were used. RNA concentration and purity was
then determined with a Picodrop microlitre Spectrophotometer
(Picodrop). Reverse transcription to cDNA was performed with
the iScript Select cDNA synthesis kit (Biorad) using the following
thermal cycle: 5 min at 25◦C, 30 min at 42◦C, 10 min at 45◦C,
10 min at 50◦C and 5 min at 85◦C.
ThemRNA expression levels of these genes were analyzedwith
SYBR green technology in quantitative real-time PCR (qRT-PCR)
using SoFast EvaGreen Supermix (Biorad) on a Bio-Rad CFX96
system according to the manufacturer’s instructions. Quantitative
PCR was carried out according to the following cycle: initial hold
at 96◦C for 30 s and then 40 cycles at 96◦C for 2 s and 60◦C for
5 s. Gene expression was normalized relative to a housekeeping
genes as previously described (Turroni et al., 2011) and reported
in Table 2. The amount of template cDNA used for each sample
was 12.5 ng.
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TABLE 2 | Primers used for RT-qPCR experiments.
Target ORF Primer Fw 5′-3′ Primer Rv 5′-3′ Size (bp)
cysE BBPR_1340 cysE-fw CGCGACCATGCGCGACTACC cysE-rv GAGGATGCGCTCGTGTCCGC 187
cysK BBPR_1344 cysK-fw CGAACCAGTACGACAACCCC cysK-rv GATGGAGCCTTCCGGATCGG 203
cysB BBPR_0960 cysB-fw GACGACCTCAAGCCGTTCCC cysB-rv GTCGCCGTTGTCGATGCCGG 189
metB BBPR_1343 metB-fw GGAGCCCGACCCGACCACCG metB-rv CAGCAGCACGTCAATCGCGG 214
metC BBPR_1226 metC-fw CATGGGTGTGGGAAGCGAGG metC-rv TCGATGTCCCAGTTGTGCCG 189
metE BBPR_0933 metE-fw GATGCTGGACACCGCGATCC metE-rv GGCGGATCTCGGTGCTCTCC 206
metA BBPR_1654 metA-fw GTTCGCTCTCGGCCATTGGG metA-rv CGGCGTGGTCTGATACACCC 205
rpoBa BBP-rpo-for GTGCAGACCGACAGCTTCGAC BBP-rpo-rev GAGATCTCGTTGAAGAACTCGTC
ldha BBP-ldh-for CACCATGAACAGGAACAAAGTTG BBP-ldh-rev GAATGATCGATGAGTACGAGCTC
atpDa BBP-atp-uni CAGAGCCGATCAATGGACGTG BBP-atp-rev GTGCTGCTCGACCTCAAGCGTGAT
aTurroni et al. (2011).
Statistical Analyses
Statistical signiﬁcance between means was analyzed using the
two way ANOVA. Statistically diﬀerent means were determined
using the Bonferroni post hoc test at 5% (P-value < 0.05).
Values are expressed as the means ± standard errors from
three experiments. Statistical calculations were performed using
the software program GraphPad Prism 5 (La Jolla, CA,
USA).
RESULTS
Development of a CDM for B. bifidum
PRL2010
We modiﬁed the previously described CDM formulations
(Petry et al., 2000; Cronin et al., 2012) based on the nutrient
requirements of B. bifidum PRL2010. Several growth attempts
on CDM minimal modiﬁcations (Petry et al., 2000; Cronin
et al., 2012), i.e., where various compounds were omitted
one after the other, allowed the identiﬁcation of a number
of components that were either essential or non-essential for
growth of PRL2010 cells. Notably, folic acid and pyridoxal were
eliminated from CDMPRL2010 composition, while guanine and
thiamine were supplemented. When testing diﬀerent sugars it
was observed that PRL2010 exhibits the best growth performance
with lactose, consistent with previous studies (Turroni et al.,
2010, 2012b), and this sugar was therefore used for CDMPRL2010
formulation.
Evaluation of Amino Acids Auxotrophy
and Prototrophy of PRL2010
When PRL2010 cells were cultivated on CDMPRL2010, they
exhibited reduced growth (OD600 value of 1.21 ± 0.3)
compared to that observed when grown on a nutrient-rich
medium such as MRS (OD600 value of 2.9 ± 0.2). In
order to assess PRL2010 amino acid prototrophy/auxotrophy,
growth experiments were performed using CDMPRL2010 where
an individual amino acid had been omitted at time, and
bCDMPRL2010 medium with the inclusion of one amino acid
at time. The achieved growth yield was compared to that
obtained for complete CDMPRL2010 or bCDMPRL2010 respectively
(Figure 2A).
In both experiments, only when cysteine was removed or
supplied to the medium a signiﬁcant decrease or increase
(ranging from four- to sixfold, P < 0.05) of the obtained growth
yield was observed, respectively, suggesting that PRL2010 is
auxotrophic for cysteine. Furthermore, PRL2010 seems unable
to grow on sulfate as its sole sulfur source, such as when this
strain is grown in bCDMPRL2010 (amedium that contains MnSO4,
MgSO4, and FeSO4).
Another reducing compound, glutathione, was added to
bCDMPRL2010 and only very limited growth was detected when
PRL2010 cells were cultivated for 24 h (OD600 value of
0.31 ± 0.038). Furthermore, we decided to investigate if taurine,
which is a common nitrogen and sulfur sources present in the
gut environment (Carbonero et al., 2012) inﬂuence the growth
yields of PRL2010. However, we did achieved any signiﬁcant grow
(OD600 = 0.10 ± 0.01) of PRL2010 when taurine was used as the
unique nitrogen and sulfur sources.
Assessing Cysteine Auxotrophy of
Members of the Genus Bifidobacterium
We further investigated the behavior of other strains belonging to
the B. bifidum species (seeTable 1), when cultivated under similar
growth conditions (Figure 2B). These experiments showed that
strains LMG11041, 156B, 85B, 324B, and LMG13195 were unable
to grow on CDMPRL2010, (OD600 values ≤ 0.3) after 24 h of
incubation (Figure 2B). The other B. bifidum strains investigated
(i.e., LMG13200, LMG11582, and LMG11583) reached OD600
values of 0.7–0.9 and exhibited an identical auxotrophic behavior
as PRL2010 for cysteine (Figure 2B).
Within the genus Bifidobacterium, the same auxotrophic
behavior for cysteine appears to be widely distributed. In fact,
of the currently recognized 48 (sub)species harboring the genus
Bifidobacterium, only B. boum LMG10736, B. minimum
LMG11592, B. pullorum LMG21816, B. ruminantium
LMG21811, B. saguini DSM23967 and B. scardovii LMG21589
were shown to be able to grow in CDMPRL2010 without cysteine,
though such strains reached OD600 values of just 0.5 ± 0.1
(Figure 2C). No biﬁdobacterial strain was able to grow in
bCDMPRL2010.
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FIGURE 2 | Continued
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FIGURE 2 | Continued
Growth of B. bifidum strains. Growth was measured as the optical density of the medium at 600 nm (OD600). Cultures were grown in triplicates. (A) Reports the
growth of B. bifidum PRL2010 in CDMPRL2010. In these tests, one amino acid at time was removed (CDM-AA) or supplied (bCDM + AA) to the medium. Amino acids
are reported in the horizontal axis as follows: aspartic acid Asp, threonine Thr, leucine Leu, tryptophan Trp, valine Val, histidine His, serine Ser, arginine Arg, isoleucine
Iso, methionine Met, lysine Lys, cysteine Cys, proline Pro, glutamine Gln, alanine Ala, glycine Gly, phenylalanine Phe and tyrosine Tyr. (B) Shows an heat map
representing the growth performance of all of the type strains of the currently recognized 48 (sub)species belonging to the genus Bifidobacterium on CDMPRL2010,
CDM-CysPRL2010 and bCDMPRL2010. The different shading represents the optical density reached by the various cultures. (C) Displays the growth of B. bifidum
strains LMG11041, 85B, 156B, 324B, LMG11583, LMG11582 LMG13200 and LMG13195 in comparison with PRL2010 in CDMPRL2010, CDMPRL2010 without
cysteine (CDM – Cys), basal CDMPRL2010 (bCDM), basal CDMPRL2010 with cysteine (bCDM + Cys) and basal CDMPRL2010 with glutathione (bCDM + Glut).
(D) Illustrates the growth of B. bifidum PRL2010 in CDMPRL2010 supplemented with complex substrates like whey proteins or casein hydrolysate. For both
substrates two concentration were tested, 0.5 and 2% (wt/wt). For every concentration was evaluated the presence of amino acid (CDM or bCDM) or other nitrogen
sources (N or w/o N).
Sulfur Amino Acid Metabolism of
B. bifidum PRL2010
A general prediction based on genomic data about nitrogen
metabolism within the genus Bifidobacterium was previously
reported by (Milani et al., 2014). The presence of genes involved
in amino acid biosynthesis appears to be conserved among the
seven phylogenetic groups of the genus Bifidobacterium (Lugli
et al., 2014). However, the genes that are predicted to be involved
in sulfur-containing amino acid metabolism were shown to be
variably present within biﬁdobacterial genomes. In this context,
an in silico analysis of the B. bifidum PRL2010 genome (Turroni
et al., 2010) for putative genes involved in sulfur-containing
amino acid transport did not reveal any positive match.
Aliphatic sulfonates can be used as alternative sulfur sources
for the synthesis of cysteine (van der Ploeg et al., 1998).
Bioinformatics analyses revealed the occurrence of two genes
(BBPR_0202 and BBPR_0362) encoding two putative ABC-type
permeases, in the chromosome of PRL2010. A low level of
homology with genes involved in sulfonate transport (Even et al.,
2006) was detected (Supplementary Table S1), possibly explaining
why B. bifidum PRL2010 cells are unable to grow with sulfate
as the only sulfur source (bCDM condition, see Figure 2A).
Another mechanism to achieve sulfur from the environment
is based on the intake of cysteine by symporter proteins. This
type of symporter may participate in the uptake of cysteine
(Vitreschak et al., 2008). In this context, a putative sodium
dicarboxylate symporter gene (BBPR_0324) was identiﬁed in
PRL2010 (see Supplementary Table S1). Moreover, two putative
genes (BBPR_0668 and BBPR_0671) predicted to encode two
carriers involved in glutamate transport system (GluA and
GluD), exhibited 53 and 26% homology, respectively, with the
genes that encode the L-cysteine uptake system of B. subtilis
(Supplementary Table S1).
As mentioned above, B. bifidum PRL2010 cells were shown to
be unable to grow in presence of reduced glutathione (and in the
absence of cysteine). Such physiological ﬁndings are in agreement
with in silico analyses of PRL2010 chromosome sequences.
In fact, the pepT and pepM genes, which are constituting
the pathway for degradation of this compound (Andre et al.,
2010) to generate cysteine, are absent in PRL2010 genome.
Furthermore, a homolog of the gshAB gene, which speciﬁes the
glutamate–cysteine ligase/glutathione synthase, is also absent in
chromosome of PRL2010 (Figure 1).
Genes predicted to be involved in the cysteine biosynthesis
I/homocysteine degradation pathway and methionine
biosynthesis I pathway were identiﬁed in PRL2010 (Figure 3A).
In silico analyses of PRL2010 genome revealed the occurrence
of the cysE (BBPR_1340) and cysK (BBPR_ 1344) genes, which
encode the predicted serine acetyltransferase that transfers an
acetyl group to serine, and the cysteine synthase, respectively
(Liu et al., 2012) (Figure 3A). In the same genomic region, we
also identiﬁed the metB gene (BBPR_1343) predicted to encode
a cystathionine-γ-synthase, which is catalyzing the conversion of
cysteine to cystathionine, as well as the luxS gene (BBPR_1341),
encoding an S-ribosylhomocysteinase involved in the production
of homocysteine, and the recQ gene (BBPR_1342) encoding
an ATP-dependent DNA helicase. When the presence of these
genes was investigated in the genomes of other B. bifidum
strains (Duranti et al., 2015) included in this study, a high
level of homology (higher than 98% at nucleotide level) was
found. Furthermore, in the genome sequences of four B. bifidum
strains, i.e., LMG13200, LMG13195, LMG11582, and LMG11583
(Duranti et al., 2015), an additional acetyltransferase-encoding
gene was identiﬁed (Figure 3A).
Other genes such as the cysB gene (BBPR_0960), metC
(BBPR_1226) and metA (BBPR_1654) that are predicted to be
involved in cysteine and methionine metabolism (Fernandez
et al., 2002; Liu et al., 2012) are scattered across the PRL2010
genome.
Growth Evaluation in Complex
Substrates
The eﬀects of complex substrates, such as whey proteins or casein
hydrolysate, on PRL2010 growth were tested and are reported in
Figure 2D. Whey proteins and casein hydrolysate were dissolved
in CDMPRL2010 and bCDMPRL2010 with or without other nitrogen
sources at 0.5 or 2% concentration (wt/wt), respectively. Casein
hydrolysate better supports PRL2010 growth in presence of
nitrogen, compared to what was observed when this strain was
cultivated on whey proteins. In CDM or bCDM without other
nitrogen sources, PRL2010 cells seemed to metabolize whey
proteins more eﬃciently as displayed by the higher OD 600 values
that were reached (Figure 2D).
Targeted Gene Expression Analyses of
PRL2010 with Different Sulfur Substrate
Transcription of genes involved in sulfur metabolism, such
as those of cysteine (cysE, cysK and cysB) and methionine
metabolism (metA, metE, metB, and metC), were investigated
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FIGURE 3 | Schematic representation of genes involved in cysteine and methionine metabolism in B. bifidum species and transcriptional analysis in
B. bifidum PRL2010. (A) Shows the genetic map of the predicted cysteine/methionine metabolism gene region identified in the genome of B. bifidum PRL2010 and
compared with other B. bifidum strains. Each individual gene is represented by an arrow and is colored or marked according to the predicted function as indicated in
the figure. (B) Reports the relative transcription levels of cysteine and methionine metabolism genes from B. bifidum PRL2010 upon cultivation in complete
CDMPRL2010, bCDMPRL2010 supplemented with cysteine (bCDM + Cys), bCDMPRL2010 supplemented with glutathione (bCDM + Glut), bCDMPRL2010 with cysteine
and 2% (wt/wt) whey protein (bCDM + Whey) and bCDMPRL2010 with cysteine and 2% (wt/wt) casein hydrolysate as analyzed by quantitative real-time PCR assays.
The histograms indicate the relative amounts of the cysE, cysK, cysB, metA, metE, metB, and metC genes mRNAs for the specific samples. The y axis indicates the
logarithmic fold induction of the investigated gene compared to the reference condition (MRS). The x axis represents the different gene tested. Asterisks indicate
statistically significant differences compared to the control. The error bar for each column represent the standard deviation calculated from three replicates.
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using a qRT-PCR approach, the results of which are reported in
Figure 3B.
When PRL2010 cells were cultivated in the complete
CDMPRL2010, cysB, cysE, cysK, metA and metB were
overexpressed (P < 0.05) (Figure 3B). The occurrence of
cysteine in the basal CDMPRL2010 (bCDM + Cys) does not
seem to modulate expression of genes involved in sulfur amino
acid metabolism. Glutathione (bCDM + Glut) does not allow a
signiﬁcant growth of PRL2010 (OD600 values of 0.31 ± 0.038).
However, it enhanced the transcription of the cysB, cysE, cysK,
metA andmetB genes (P < 0.05).
Regarding complex substrates, cys genes appear to be less
induced when PRL2010 cells are cultivated in whey protein
compared to basal CDMPRL2010 in the presence of casein
hydrolysate (bCDM + Whey and bCDM + Casein respectively
in Figure 3B), although at signiﬁcant level (P < 0.05). Moreover,
casein hydrolysate signiﬁcantly increases the transcription level
ofmetC, the cystathionine β-liase (P < 0.05).
In all conditions tested, no signiﬁcant transcriptional changes
were detected for the metC and metE genes predicted to encode
for cystathionine β-liase and homocysteine methyltransferase,
respectively, except for metC when PRL2010 was grown in
bCDMPRL2010 with casein hydrolysate.
DISCUSSION
Following birth, the human intestine is rapidly colonized by a
vast array of microorganisms. Bifidobacterium, and in particular,
B. bifidum strains are abundant in breast-fed infants, due to their
capacity to grow on mucin and on human milk oligosaccharides
(Turroni et al., 2010). The biﬁdogenic eﬀect of breast milk due
to bioactive peptides presence is well known (Liepke et al., 2002).
A similar biﬁdogenic eﬀect was shown for milk-derived k-caseins
with loss of activity when the disulﬁde bonds were oxidized (Poch
and Bezkorovainy, 1991).
Here, we investigated for the ﬁrst time sulfur-containing
amino acid metabolism in B. bifidum PRL2010 through the
development of a CDM called CDMPRL2010 and by the molecular
characterization of the putative auxotrophic behavior of this
strain for cysteine. Data indicates that bCDMPRL2010 does
not support B. bifidum PRL2010 growth, unless cysteine
addition. The same behavior was extended to three other
B. bifidum strains, i.e., LMG13200, LMG11582 and LMG11583.
Furthermore, cysteine auxotrophy is not a common feature of
all the (sub)species harboring the genus Bifidobacterium, since
representatives of some species such as B. boum, B. minimum,
B. pullorum, B. ruminantium, B. saguini and B. scardovii are able
to grow without cysteine, although rather poorly.
In silico analyses of PRL2010 genome did not reveal the
presence of the genetic arsenal needed to sulfate transport and
reduction to sulﬁde. Growth experiments showed that cysteine
is the only amino acid necessary to sustain PRL2010 growth
but when the strain is cultivated in basal CDMPRL2010 with
cysteine (bCDM + Cys) the transcription of genes involved in
cysteine and methionine metabolism was not stimulated by the
availability of these amino acid residues. Similar results were
reported previously for other bacterial species, such as Escherichia
coli (Kredich, 1992), Bacillus subtilis (Mansilla and de Mendoza,
2000), and Lactococcus lactis (Fernandez et al., 2002). Another
reduced sulfur compound was used to understand if the role
of cysteine in PRL2010 is linked to the reducing eﬀect that it
exploits on the redox potential (Even et al., 2006). However,
reduced glutathione does not sustain any appreciable strain
growth, yet enhanced the transcription of genes predicted to
be involved in sulfur amino acid metabolism (cysB, cysE, cysK,
metA and metB). Similar behavior was previously reported for
E. coli (Kredich, 1992) and B. subtilis (Mansilla and de Mendoza,
2000).
Complex substrates from dairy industry such as whey proteins
and casein hydrolysate act as a reservoir of amino acid, peptides
and free protein. Transcriptional analysis showed that whey
proteins and casein hydrolysate increased the transcriptions
of genes involved in serine degradation and/or conversion to
cysteine and methionine (cysB, cysE, cysK metA andmetB).
CONCLUSION
This study provides new insights into the amino acid utilization
ability of the B. bifidum species. This work also suggested
the existence of a relationship between the sulfur amino
acid metabolism and the redox state of the cell. The use of
complex nitrogen sources available in the infant gut revealed an
enhancement of growth yield and expression of genes involved
in sulfur amino acid metabolism in PRL2010. These results
could open a new avenue of research for the development
of novel functional foods based on milk caseins and whey
proteins with high content of cysteine or cysteine precursor’s
compounds that could act as prebiotics for Bifidobacterium
enrichment.
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